Markets

Options Traders Expect Huge Moves in Conatus Pharmaceuticals (CNAT) Stock

Investors in shares of Conatus Pharmaceuticals Inc.CNAT need to pay close attention to the stock based on moves in the options market lately. That is because the Call which expires on Jan 20, 2017 for the $2.50 strike price had some of the highest implied volatility of all equity options today.

What is Implied Volatility?

Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility could mean that investors in the underlying stocks are expecting a big move in one direction or the other. It could also mean there is an event coming up soon that could cause a big rally or a huge sell off. However, implied volatility is only one piece of the puzzle when putting together an options trading strategy.

What do the Analysts Think?

Clearly, options traders are pricing in a big move for Conatus Pharmaceuticals shares, but what is the fundamental picture for the company? Currently, Conatus Pharmaceuticals is a Zacks Rank #3 (Hold) in the Medical - Products industry that ranks in the bottom 45% of our Zacks Industry Rank. Over the last 60 days, four analysts have increased their earnings estimates for the current quarter, while one has dropped the estimate. The net effect has taken our Zacks Consensus Estimate for the current quarter from a loss of 33 cents per share to a loss of 32 cents per share in that period.

Given the way analysts feel about Conatus Pharmaceuticals right now, this huge implied volatility could mean there's a trade developing. Often times, options traders look for options with high levels of implied volatility to sell premium. This is a strategy many seasoned traders use because it captures decay. At expiration, the hope for these traders is that the underlying stock does not move as much as originally expected.

Looking to Trade Options?

Each week, our very own Dave Bartosiak gives his top options trades. Check out his recent live analysis and options trade for the LULU earnings report completely free. See it here: Bartosiak: Trading Lululemon (LULU) Earnings with Options or check out the embed video below for more details:

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

CONATUS PHARMA (CNAT): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

CNAT

Other Topics

Investing Stocks

Latest Markets Videos